RNAi Roundtable: Givosiran, for the Treatment of Acute Hepatic Porphyria

RNAi Roundtable: Givosiran, for the Treatment of Acute Hepatic Porphyria

On August 4, 2021, we hosted an online RNAi Roundtable to review the progress with givosiran, for the treatment of acute hepatic porphyria.

Access the replay
View the presentation
Read the transcript

Akin Akinc, Ph.D.
Vice President & General Manager, Givosiran

Marianne Sweetser, M.D., Ph.D.
Senior Distinguished Fellow, Clinical Development

Laurent Placidi, Ph.D., PharmD.
Senior Director, Global Marketing, Givosiran



SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.